Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus metformin versus aspirin plus placebo for prevention of preeclampsia in high-risk pregnant women
IRCT20140317017035N9Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Aspirin + placebo with Aspirin + metformin (2 arms). Primary endpoints: Prevention of preeclampsia and Decrease in fetal mortality and morbidity due to preeclampsia. Started May 2024; status: completed.
02
Drugs
aspirinmetformin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20140317017035N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140317017035N9.